The results of multiple databases further confirmed the lower expression of FDX1 in HCC tissues (Figure 1D). Survival analysis showed that higher FDX1 expression correlated with better OS of HCC patients in GSE14520, TCGA-LIHC, and ICGC-LIRI-JP (Figure 1E). Here, FDX1 is linked to hepatocellular carcinoma.